Replies to post #14959 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

tcm55

This was a company decision, the FDA did Not say it was futile/ineffective or had safety issues, Right?

We don't know what the FDA said.

As stated by smoki

CM you should share the letter you received from the FDA about Covid-19 and the date you received it ... you owe that much to your shareholder’s.

We'll never get a clear understanding other than the dilution that came with the covid angle and dropping the ball with getting to a data readout for IPF/CC. Think about it...but for the balls to the wall efforts to chase covid...AP will be 3 years into its "Repurposed Drugs" strategy and still not have its first data readout for a 20 participant clinical trial. That's insanity and pure incompetence on the part of management/team cobra. But whatever....in that time frame Kulwant Malhi has flipped shares of AP for millions in profits for Growmax (Him/Wife owns lions share) and the CEO and the rest of Team Cobra has fallen in line and reap the rewards of salaries/bonuses across a spectacle of pennyland junk stock companies all tied to Kulwant Malhi - Algernon Pharmaceuticals largest individual shareholder. Anyone think those shares haven't been flipped as well? If one were the boss of Algernon's CEO and CFO at some point in the process, who wouldn't take advantage of having maximum leverage over those who supposedly direct Algernon Pharmaceuticals (Rajpaul Attariwala, Michael Sadhra, David Levine)? Rhetorically speaking because we all know the answer to that question.

Get to full enrollment and get me the goddamn data results!

M$

Outro